Filing Details
- Accession Number:
- 0000899243-21-002241
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-15 20:31:13
- Reporting Period:
- 2021-01-13
- Accepted Time:
- 2021-01-15 20:31:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501134 | Invitae Corp | NVTA | Services-Medical Laboratories (8071) | 271701898 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1689575 | Katherine Stueland | C/O Invitae Corporation 1400 16Th Street San Francisco CA 94103 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-13 | 4,199 | $10.94 | 207,251 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-13 | 232 | $48.50 | 207,019 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 400 | $49.88 | 206,619 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 1,567 | $51.55 | 205,052 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 1,600 | $52.71 | 203,452 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-01-13 | 400 | $53.23 | 203,052 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Options (Right to Buy) | Disposition | 2021-01-13 | 4,199 | $0.00 | 4,199 | $10.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,801 | 2025-09-09 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 166,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on September 15, 2020.
- Represents a weighted average sale price. Actual sale prices ranged from $48.32 to $48.73 per share.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents a weighted average sale price. Actual sale prices ranged from $49.55 to $50.20 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $50.97 to $51.88 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $52.09 to $53.03 per share.
- Represents a weighted average sale price. Actual sale prices ranged from $53.11 to $53.41 per share.
- The shares subject to this option are fully vested and exercisable.
Billionaire Hedge Funds
